We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$4.31B
AUM Growth
+$222M
Cap. Flow
+$277M
Cap. Flow %
6.44%
Top 10 Hldgs %
18.96%
Holding
2,575
New
116
Increased
713
Reduced
638
Closed
110

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Financials 3.89%
3 Industrials 3.72%
4 Healthcare 2.96%
5 Energy 2.89%

No holdings matched the selected filter criteria.

Similar funds

Geneos Wealth Management's Q1 2026 Portfolio in Review

As of Q1 2026, Geneos Wealth Management held 2,575 positions worth $4.31B, up 5.4% from $4.09B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneos Wealth Management deployed $277M of net new capital in Q1 2026, opening 116 new positions and adding to 713 existing holdings. Its largest new stake was iShares Systematic Bond ETF: 84,595 shares worth $7.53M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 7.6% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Capital Group Growth ETF, an estimated $27.9M trimmed.

  • Geneos Wealth Management's largest Q1 2026 buy was iShares Systematic Bond ETF: 84,595 shares worth $7.53M.
  • Geneos Wealth Management added most to iShares Core S&P Total US Stock Market ETF in Q1 2026, an estimated $54.8M increase.
  • Geneos Wealth Management's biggest Q1 2026 reduction was Capital Group Growth ETF, cutting an estimated $27.9M.
  • Geneos Wealth Management fully exited AstraZeneca in Q1 2026, selling an estimated $7.53M.
  • Geneos Wealth Management's ten largest holdings make up 19% of its $4.31B portfolio in Q1 2026.
  • Geneos Wealth Management opened 116 new positions and closed 110 in Q1 2026.
  • Geneos Wealth Management's portfolio value rose 5.4% quarter-over-quarter to $4.31B.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.